| Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma (NCT05190263) | AIO-Studien-gGmbH | 2021-10-25 |
| CPAP or BiPAP for Motion Mitigation During Radiotherapy (NCT04986293) | University Medical Center Groningen | 2021-06-01 |
| Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden (NCT04760184) | Uppsala University | 2021-04-01 |
| HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation (NCT04464889) | Medigene AG | 2020-07-02 |
| Lean Body Mass and Side Effects in Patients With Lymphoma (NCT04698616) | Jens Rikardt Andersen | 2020-02-09 |
| TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma (NCT03346096) | Sheba Medical Center | 2018-10-09 |
| Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma (NCT03316144) | Shanghai Junshi Bioscience Co., Ltd. | 2017-07-12 |
| Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study (NCT02678299) | University of Aarhus | 2016-02-01 |
| Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients (NCT03062072) | National Cancer Center, Korea | 2015-04-01 |
| Phase I Study of Mitoxantrone Hydrochloride Liposome Injection (NCT02131688) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2013-05-01 |
| Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma (NCT01588548) | AstraZeneca | 2012-07-01 |
| Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma (NCT01473095) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2011-11-01 |
| Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer (NCT01324310) | Celgene | 2011-04-01 |
| Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? (NCT00892502) | Copenhagen University Hospital at Herlev | 2009-05-01 |
| Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas (NCT00685997) | UMC Utrecht | 2008-06-01 |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00683046) | University of Chicago | 2001-11-01 |
| Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies (NCT01499147) | University of Illinois at Chicago | 2000-02-01 |
| Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma (NCT01016795) | Aalborg University Hospital | 1999-01-01 |